Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice

Randy Strong(The University of Texas at San Antonio Health Science Center), James F. Nelson(The University of Texas at San Antonio Health Science Center), Suja Kumar(University of Michigan), Vivian Diaz, Molly A. Bogue(Jackson Laboratory), Jonathan Gelfond(The University of Texas at San Antonio Health Science Center), Eric Verdin(Buck Institute for Research on Aging), Benjamin F. Miller(Oklahoma Medical Research Foundation), Jonathan Dorigatti(The University of Texas at San Antonio Health Science Center), Shailaja Allani(Florida Atlantic University), Marisa Lopez‐Cruzan(The University of Texas at San Antonio Health Science Center), Brett C. Ginsburg(The University of Texas at San Antonio Health Science Center), Herbert Weissbach(Atlantic University), Nadia Rosenthal(Jackson Laboratory), Adam B. Salmon(The University of Texas at San Antonio Health Science Center), Kerry Kornfeld(Washington University in St. Louis), Martin A. Javors(The University of Texas at San Antonio Health Science Center), Francesca Maccchiarini(National Institute on Aging), Peter S. Rabinovitch(University of Washington), Peter C. Reifsnyder(Jackson Laboratory), Richard A. Miller(University of Manitoba), Angela O. Dorigatti(The University of Texas at San Antonio Health Science Center), Matt Kaeberlein(University of Washington), Yousin Suh(Columbia University Irving Medical Center), David B. Lombard(Sylvester Comprehensive Cancer Center), Catherine Cheng(The University of Texas at San Antonio Health Science Center), Andrzej T. Gałecki(University of Michigan), Karyn L. Hamilton(Colorado State University), Elizabeth Fernández(The University of Texas at San Antonio Health Science Center)
Aging Cell
September 30, 2022
Cited by 72


Related Papers